Frederic H Vaillancourt

Summary

Affiliation: Boehringer Ingelheim

Publications

  1. pmc Evaluation of phosphatidylinositol-4-kinase IIIα as a hepatitis C virus drug target
    Frederic H Vaillancourt
    Boehringer Ingelheim Ltd, Laval, Quebec, Canada
    J Virol 86:11595-607. 2012
  2. doi request reprint Identification of a lipid kinase as a host factor involved in hepatitis C virus RNA replication
    Frederic H Vaillancourt
    Boehringer Ingelheim Canada Ltd, 2100 Cunard St, Laval, QC, Canada H7S 2G5
    Virology 387:5-10. 2009
  3. pmc Phosphatidylinositol 4-kinase III beta is essential for replication of human rhinovirus and its inhibition causes a lethal phenotype in vivo
    Catherine Spickler
    Boehringer Ingelheim Canada Ltd, Laval, Quebec, Canada
    Antimicrob Agents Chemother 57:3358-68. 2013

Collaborators

Detail Information

Publications3

  1. pmc Evaluation of phosphatidylinositol-4-kinase IIIα as a hepatitis C virus drug target
    Frederic H Vaillancourt
    Boehringer Ingelheim Ltd, Laval, Quebec, Canada
    J Virol 86:11595-607. 2012
    ..This essential host physiologic role raises doubt about the pursuit of PI4KIIIα inhibitors for treatment of chronic HCV infection...
  2. doi request reprint Identification of a lipid kinase as a host factor involved in hepatitis C virus RNA replication
    Frederic H Vaillancourt
    Boehringer Ingelheim Canada Ltd, 2100 Cunard St, Laval, QC, Canada H7S 2G5
    Virology 387:5-10. 2009
    ....
  3. pmc Phosphatidylinositol 4-kinase III beta is essential for replication of human rhinovirus and its inhibition causes a lethal phenotype in vivo
    Catherine Spickler
    Boehringer Ingelheim Canada Ltd, Laval, Quebec, Canada
    Antimicrob Agents Chemother 57:3358-68. 2013
    ..Mortality was seen in all dosing groups of mice treated with either compound, therefore suggesting that short-term inhibition of PI4KIIIβ is deleterious...